Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: A pilot study

Dermatologic Therapy

Volumn 22, Issue SUPPL. 1, 2009, Pages

  Lacarrubba, Francesco ^a   Nardone, Beatrice ^a   Musumeci, Maria Letizia ^a   Micali, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Clobetasol propionate 0.05 foam; Healthy skin; Psoriasis; Ultrasound

Indexed keywords

CLOBETASOL PROPIONATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ECHOGRAPHY; FEMALE; FOAM; FOREARM; HUMAN; MALE; PILOT STUDY; PSORIASIS VULGARIS; SKINFOLD THICKNESS; TOPICAL TREATMENT; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSORIASIS; SKIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72449211748     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2009.01267.x     Document Type: Article

References (10)

1. Vaillant L, Berson M, Machet L, Callens A, Pourcelot L, Lorette G. Ultrasound imaging for psoriatic skin: a noninvasive technique to evaluate treatment of psoriasis. Int J Dermatol 1994 : 33 : 786 790.
2. Cossmann M, Welzel J. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial. Br J Dermatol 2006 : 155 : 700 706.
3. Kersher MJ, Korting HC. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound. Acta Derm Venereol 1992 : 72 : 214 216.
4. Korting HC, Vieluf D, Kerscher M. Ultrasound assessment of the comparative atrophogenicity of potent fluorinated and nonfluorinated topical glucocorticoids. In : Altmeyer P, el-Gammal S, Hoffmann K, eds. Ultrasound in dermatology. Berlin, Germany : Springer-Verlag, 1992 : 250 255.
5. Hoffmann K, el-Gammal S, Schwarze H, Dirschka T, Altmeyer P. Examination of Psoriasis vulgaris using 20-MHz B-scan ultrasound. In : Altmeyer P, el-Gammal S, Hoffmann K, eds. Ultrasound in dermatology. Berlin, Germany : Springer-Verlag, 1992 : 244 249.
6. Franz TJ, Parsell DA, Myers JA, Hannigan JF. Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery. Int J Dermatol 2000 : 39 : 535 538.
7. Lebwohl M, Sherer D, Washenik K, et al. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of non-scalp psoriasis. Int J Dermatol 2002 : 41 : 269 274.
8. Gottlieb AB, Ford R, Spellmann MC. The efficacy and tolerability of clobetasol-propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of non-scalp regions. J Cutan Med Surg 2003 : 7 : 185 192.
9. West DP, Loyd A, West LE, Bauer KA, Musumeci ML, Micali G. Psoriasis. In : DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach, 7th ed. New York, NY : McGraw-Hill, 2008 : 1603 1617.
10. Huang X, Tanojo H, Lenn J, Deng CH, Krochmal L. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol 2005 : 53 : S26 S38.